AED Stock Overview
Aedes SIIQ (MTA:AED) was founded and at the same time listed on the Electronic Stock Market of Borsa Italiana, following the proportional partial division of Restart (a company founded in 1905 and listed on the Milan Stock Exchange since 1924) on December 28, 2018.
Aedes SIIQ Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€0.24|
|52 Week High||€0.35|
|52 Week Low||€0.16|
|1 Month Change||-15.81%|
|3 Month Change||-12.87%|
|1 Year Change||33.90%|
|3 Year Change||-83.93%|
|5 Year Change||n/a|
|Change since IPO||-78.84%|
Recent News & Updates
|AED||IT REITs||IT Market|
Return vs Industry: AED exceeded the Italian REITs industry which returned -10.6% over the past year.
Return vs Market: AED exceeded the Italian Market which returned -15.6% over the past year.
|AED Average Weekly Movement||10.0%|
|REITs Industry Average Movement||3.3%|
|Market Average Movement||5.1%|
|10% most volatile stocks in IT Market||7.2%|
|10% least volatile stocks in IT Market||3.3%|
Stable Share Price: AED is more volatile than 90% of Italian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: AED's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Italian stocks.
About the Company
Aedes SIIQ (MTA:AED) was founded and at the same time listed on the Electronic Stock Market of Borsa Italiana, following the proportional partial division of Restart (a company founded in 1905 and listed on the Milan Stock Exchange since 1924) on December 28, 2018. Aedes SIIQ has an income and development real estate portfolio to be developed to be put into income in line with the strategy of an SIIQ with destination Commercial (Retail and Office).
Aedes SIIQ Fundamentals Summary
|AED fundamental statistics|
Is AED overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|AED income statement (TTM)|
|Cost of Revenue||€9.23m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.18|
|Net Profit Margin||-309.41%|
How did AED perform over the long term?See historical performance and comparison
Is AED undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AED?
Other financial metrics that can be useful for relative valuation.
|What is AED's n/a Ratio?|
Price to Sales Ratio vs Peers
How does AED's PS Ratio compare to its peers?
|AED PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
Price-To-Sales vs Peers: AED is good value based on its Price-To-Sales Ratio (4.1x) compared to the peer average (6.1x).
Price to Earnings Ratio vs Industry
How does AED's PE Ratio compare vs other companies in the REITs Industry?
Price-To-Sales vs Industry: AED is good value based on its Price-To-Sales Ratio (4.1x) compared to the European REITs industry average (10.7x)
Price to Sales Ratio vs Fair Ratio
What is AED's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||4.1x|
|Fair PS Ratio||n/a|
Price-To-Sales vs Fair Ratio: Insufficient data to calculate AED's Price-To-Sales Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of AED when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate AED's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate AED's fair value for valuation analysis.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AED's PEG Ratio to determine if it is good value.
Discover undervalued companies
How is Aedes SIIQ forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Real Estate industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Aedes SIIQ has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Aedes SIIQ competitive advantages and company strategy can generally be found in its financial reports archived here.
How has Aedes SIIQ performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AED is currently unprofitable.
Growing Profit Margin: AED is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: AED is unprofitable, and losses have increased over the past 5 years at a rate of 59.5% per year.
Accelerating Growth: Unable to compare AED's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AED is unprofitable, making it difficult to compare its past year earnings growth to the REITs industry (94.6%).
Return on Equity
High ROE: AED has a negative Return on Equity (-21.56%), as it is currently unprofitable.
Discover strong past performing companies
How is Aedes SIIQ's financial position?
Financial Health Score0/6
Financial Health Score 0/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: AED's short term assets (€33.4M) do not cover its short term liabilities (€118.1M).
Long Term Liabilities: AED's short term assets (€33.4M) do not cover its long term liabilities (€78.9M).
Debt to Equity History and Analysis
Debt Level: AED's net debt to equity ratio (72.2%) is considered high.
Reducing Debt: Insufficient data to determine if AED's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AED has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AED has less than a year of cash runway if free cash flow continues to reduce at historical rates of 43.5% each year
Discover healthy companies
What is Aedes SIIQ current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AED's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AED's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as AED has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Aedes SIIQ has no CEO, or we have no data on them.
Experienced Board: AED's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 708.3%.
Aedes SIIQ S.p.A.'s employee growth, exchange listings and data sources
- Name: Aedes SIIQ S.p.A.
- Ticker: AED
- Exchange: BIT
- Founded: NaN
- Industry: Diversified REITs
- Sector: Real Estate
- Implied Market Cap: €66.504m
- Shares outstanding: 280.61m
- Website: https://www.aedes-siiq.com
Number of Employees
- Aedes SIIQ S.p.A.
- Via Tortona 37
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/26 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.